CNN2 and hepatocellular carcinoma: In order to confirm the specificity of CNN2 autoantibodies in the serum of HCC patients and the correlation between the expression of CNN2 in HCC tissues and the proliferation and metastasis of HCC cells, we employed SEREX technology to detect CNN2 autoantibodies in the serum of HCC patients, hepatitis patients, and patients with other cancers.